Eli Lilly's diabetes drug wins FDA approval to lower heart attack and stroke risk
The diabetes drug, already the top-prescribed branded type 2 diabetes medicine in the U.S., showed an 8% lower rate of major heart events than Lilly's older drug Trulicity
We haven't written up this one. Quartz has the full story — the link below goes straight to it.
This story
This is one outlet's version. Read the fullest account.
- Pfizer-backed Priovant wins FDA approval for lead asset seekingalpha.com